Xenthiorate

This classification denotes an anti-lipidemic agent with the molecular formula C22H29NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0PM0Q96HVS, chemically known as 4-biphenylacetic acid, alpha-ethylthio-, s-(2-(diethylamino)ethyl) ester but generally known as xenthiorate, which bears US NIH Compound Identifier 6445348. European Medicines Agency schedules Xenthiorate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00105MIG. The term XENTHIORATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). XENTHIORATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xenthiorate under HS 29309085 and SITC 51549. As of Q4 2014, XENTHIORATE remains the US FDA Preferred Term for this commodity. Xenthiorate bears US NLM identifiers UMLS ID C1883574 and NCI Concept Code C66665. SMILES: S(CCN(CC)CC)C(=O)C(CC)c1ccc(cc1)c1ccccc1.